Eifelhoehen-Klinik AG (DE:EIF)
FRANKFURT:EIF

Eifelhoehen-Klinik AG (EIF) Stock Price & Analysis

0 Followers

EIF Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.61 - €2.38
Previous Close€1.42
Volume0.00
Average Volume (3M)695.00
Market Cap
€4.28M
Enterprise Value€16.45M
Total Cash (Recent Filing)€5.15M
Total Debt (Recent Filing)€16.56M
Price to Earnings (P/E)1.9
Beta-0.43
Sep 30, 2024
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.74
Shares Outstanding3,120,000
10 Day Avg. Volume0
30 Day Avg. Volume695
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

EIF FAQ

What was Eifelhoehen-Klinik AG’s price range in the past 12 months?
Eifelhoehen-Klinik AG lowest stock price was €0.60 and its highest was €2.38 in the past 12 months.
    What is Eifelhoehen-Klinik AG’s market cap?
    Currently, no data Available
    When is Eifelhoehen-Klinik AG’s upcoming earnings report date?
    Eifelhoehen-Klinik AG’s upcoming earnings report date is Sep 30, 2024 which is in 68 days.
      How were Eifelhoehen-Klinik AG’s earnings last quarter?
      Eifelhoehen-Klinik AG released its earnings results on Apr 30, 2024. The company reported €0.919 earnings per share for the quarter, beating the consensus estimate of N/A by €0.919.
        Is Eifelhoehen-Klinik AG overvalued?
        According to Wall Street analysts Eifelhoehen-Klinik AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Eifelhoehen-Klinik AG pay dividends?
          Eifelhoehen-Klinik AG pays a Notavailable dividend of €0.41 which represents an annual dividend yield of N/A. See more information on Eifelhoehen-Klinik AG dividends here
            What is Eifelhoehen-Klinik AG’s EPS estimate?
            Eifelhoehen-Klinik AG’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Eifelhoehen-Klinik AG have?
            Eifelhoehen-Klinik AG has 3,120,000 shares outstanding.
              What happened to Eifelhoehen-Klinik AG’s price movement after its last earnings report?
              Eifelhoehen-Klinik AG reported an EPS of €0.919 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.785%.
                Which hedge fund is a major shareholder of Eifelhoehen-Klinik AG?
                Currently, no hedge funds are holding shares in DE:EIF
                ---

                Eifelhoehen-Klinik AG Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Fundamentals

                Return on Equity
                21.73%
                Trailing 12-Months
                Asset Growth
                -4.29%
                Trailing 12-Months

                Company Description

                Eifelhoehen-Klinik AG

                Eifelhoehen-Klinik AG operates rehabilitation hospitals. It offers facilities for outpatient and inpatient rehabilitation, geriatric care and outpatient medical care. It has branches involved in therapy, neurology, orthopedic, and heart related medicine and surgery.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Bastfaserkontor AG
                MATERNUS-Kliniken AG
                Gesundheitswelt Chiemgau AG
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis